Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.190
+0.060 (2.82%)
Oct 19, 2026, 10:52 AM EDT - Market open
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Zentalis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $7.44. The average 1-year stock price forecast is 239.73% higher than the current stock price, while the lowest is $5.00 (+128.31%) and the highest is $10 (+356.62%).
Price Target: $7.44 (+239.73%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zentalis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 6 | 8 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +356.62% | Oct 19, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Upgrades $4 → $8 | Buy | Upgrades | $4 → $8 | +265.30% | Oct 5, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $5 | Hold | Maintains | $5 | +128.31% | Sep 30, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 15, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +265.30% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.81M
EPS This Year
-2.02
from -1.80
EPS Next Year
-1.82
from -2.02
EPS and Forward PE are based on non-GAAP adjusted numbers.